The NRC is modernizing nrc.gov with an updated design and improved navigation to enhance usability. We are committed to a smooth transition and will work to minimize any disruption. The site may be briefly unavailable at times during launch. Thank you for your patience.
Event Notification Report for May 10, 2023
U.S. Nuclear Regulatory Commission
Operations Center
EVENT REPORTS FOR
05/09/2023 - 05/10/2023
EVENT NUMBERS
56633
Hospital
Event Number: 56633
Rep Org: North Kansas City Hospital
Licensee: North Kansas City Hospital
Region: 3
City: Kansas City State: MO
County:
License #: 24-17561-01
Agreement: N
Docket:
NRC Notified By: Karen Hopping
HQ OPS Officer: Karen Cotton-Gross
Licensee: North Kansas City Hospital
Region: 3
City: Kansas City State: MO
County:
License #: 24-17561-01
Agreement: N
Docket:
NRC Notified By: Karen Hopping
HQ OPS Officer: Karen Cotton-Gross
Notification Date: 07/21/2023
Notification Time: 17:00 [ET]
Event Date: 05/10/2023
Event Time: 00:00 [CDT]
Last Update Date: 07/21/2023
Notification Time: 17:00 [ET]
Event Date: 05/10/2023
Event Time: 00:00 [CDT]
Last Update Date: 07/21/2023
Emergency Class: Non Emergency
10 CFR Section:
35.3047(a) - Embryo/Fetus Dose > 50 Msv
10 CFR Section:
35.3047(a) - Embryo/Fetus Dose > 50 Msv
Person (Organization):
Hills, David (R3DO)
NMSS_EVENTS_NOTIFICATION (EMAIL)
Williams, Kevin (MSST-DIR)
Hills, David (R3DO)
NMSS_EVENTS_NOTIFICATION (EMAIL)
Williams, Kevin (MSST-DIR)
DOSE TO AN EMBRYO
The following information is a summary of a phone call with the North Kansas City Hospital Radiation Safety Officer (RSO):
On May 10, 2023, a nuclear medicine tech administered 125.7 mCi of I-131 to a patient for the thyroid cancer ablation at North Kansas City Hospital. The patient had received a pregnancy test on May 8, 2023, which was negative.
On July 21, 2023, the hospital was notified that the patient was pregnant with an estimated fetal age of 7-10 weeks which would have had the patient pregnant at the time of administration, or shortly thereafter. This event is being reported because of the potential for a dose to the embryo.
At this time there are no known negative effects to the patient.
The following information is a summary of a phone call with the North Kansas City Hospital Radiation Safety Officer (RSO):
On May 10, 2023, a nuclear medicine tech administered 125.7 mCi of I-131 to a patient for the thyroid cancer ablation at North Kansas City Hospital. The patient had received a pregnancy test on May 8, 2023, which was negative.
On July 21, 2023, the hospital was notified that the patient was pregnant with an estimated fetal age of 7-10 weeks which would have had the patient pregnant at the time of administration, or shortly thereafter. This event is being reported because of the potential for a dose to the embryo.
At this time there are no known negative effects to the patient.